Isshiki Yusuke - Department of Hematology, Chiba University Hospital

基本信息

浏览量：17

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 49 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma

Efrat Shema,Ofir Griess,Noa Furth,Nofar Harpaz, Nicoletta Di Bernardo,Tomer Meir Salame,Bareket Dassa,Ioannis Karagiannidis,Yusuke Isshiki,Menachem Gross,Ari M Melnick,Wendy Beguelin,Guy Ron

biorxiv（2024）

引用0浏览0引用

Abstract PO-040: Mechanisms of Action of Immune Checkpoint Blockade Therapy in EZH2/Bcl2-mutant B-cell Lymphomas

Alexey V. Sarapulov,Serganova Inna,Ryan Bucktrout,Yusuke Isshiki,Anthony Santella, Marc-Anthony Rodriguez,Sanjukta Chakraborty, Solene Brunschvig,Santosha A. Vardhana,Claudio Tripodo,Ari Melnick,Wendy Béguelin,Roberta Zappasodi

Blood cancer discoveryno. 3_Supplement (2024): PO-040

引用0浏览0引用

Development of Syngeneic Murine Cell Lines of Germinal Center-Derived B-Cell Lymphomas

Henna S. Nam,Yusuke Isshiki,Min Xia, Sanket Shah,Meng Li,Ioannis Karagiannidis,Matthew Teater,Ari M. Melnick, Wendy Baguelin

Bloodno. Supplement 1 (2023): 4365-4365

引用0浏览0引用

Future Prospects for Targeting the Epigenome in Lymphomas

Yusuke Isshiki,Ari Melnick

Precision Cancer Therapies, Volume 1 ‐ Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignanciespp.236-248, (2023)

引用0浏览0引用

EZH2 Inhibitors Enhance CART Cell Quality, Efficacy, in Vivo Homing, Tumor Cell Binding and Killing of Fully Syngeneic Primary B Cell Lymphomas, As Well As Reprogramming Lymphoma Cells to a Highly Immunogenic and T Cell Adherent Phenotype

Yusuke Isshiki,Patrizia Porazzi,Xi Chen,Matthew Teater,Ioannis Karagiannidis, Henna S. Nam,Ari M. Melnick,Marco Ruella, Wendy Baguelin

Bloodno. Supplement 1 (2023): 432-432

引用0浏览0引用

[Identification of Transcriptional Features and Surface Markers of Plasma Cell Clones in POEMS Syndrome by Single-Cell RNA Sequencing]

Yusuke Isshiki,Motohiko Oshima,Naoya Mimura,Emiko Sakaida,Atsushi Iwama

PubMedno. 7 (2023): 581-585

引用0浏览0WOS引用

Enhancing T‐cell Responses to GCB‐like Lymphomas with Immune‐checkpoint‐blockade‐based Therapies

Inna Serganova,Ryan Bucktrout,Yusuke Isshiki, Alexey V. Sarapulov,Anthony Santella, Melissa Rodriguez,Sanjukta Chakraborty, Solene Brunschvig,David Qualls,Santosha A. Vardhana, Alexander M. Lesokhin,Ari Melnick,Wendy Béguelin,Roberta Zappasodi

Hematological oncologyno. S2 (2023): 280-280

引用0浏览0引用

Inhibition of EZH2 Improves CART19 Immunotherapy by Reprogramming Lymphoma Tumor Cells and Enhancing T-Cell Functionality

Patrizia Porazzi,Yusuke Isshiki,Guido Ghilardi, Siena Nason, Ziqi Yang,Alberto Carturan,Linhui Chen,Yunlin Zhang,Ruchi P. Patel,Puneeth Guruprasad,Ositadimma Ugwuanyi,Ivan J. Cohen,Stephen J. Schuster,Ari M. Melnick, Wendy Baguelin,Marco Ruella

Bloodno. Supplement 1 (2023): 1018-1018

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn